p53 Regulates apoptosis in human retinoblastoma

Archives of Ophthalmology

Volumn 115, Issue 2, 1997, Pages 213-219

  Michael Nork, T ^a,b,c,d   Poulsen, Gretchen L ^a,b,c,d   Millecchia, Lyndell L ^a,b,c,d   Jantz, Robert G ^a,b,c,d   Nickells, Robert W ^a,b,c,d  

^a Department ^*  (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c Department of Ophthalmology   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA FRAGMENT; PROTEIN P53; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; DNA DEGRADATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOSIS INHIBITION; PRIORITY JOURNAL; RETINOBLASTOMA; TUMOR CELL LINE;

EID: 0031044873     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1997.01100150215011     Document Type: Article

References (29)

1. Knudson AJ. Mutation and childhood cancer: statistical study of retinoblastoma. Pmc NatlAcad Sei USA. 1971:68:820-823.
2. Hamel PA, Phillips RA, Muncaster M, Gallie BL Speculations on the roles of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression. FASEB J. 1993:7:846-854.
3. Tso MO, Fine BS, Zimmerman LE. The nature of retinoblastoma, II: photoreceptor differentiation: an electron microscopic study. Am J Ophthalmol. 1970; 69:350-359.
4. Nork TM, Schwartz TL, Doshi HM, Millecchia LL. Retinoblastoma: cell of origin. Arch Ophthalmol. 1995;113:791-802.
5. Büchi ER, Bernauer W, Daicker B. Cell death and disposal in retinoblastoma: an electron microscopic study. Graefe'sArch Clin Exp Ophthalmol. 1994;232: 635-645.
6. Schultz KR, Ranade S, Neglia JP, Ravindranath Y. An increased relative frequency of retinoblastoma at a rural regional referral hospital in Miraj, Maharashtra, India. Cancer. 1993;72:282-286.
7. Shields CL, Shields JA, Baez KA, Cater J, De Potter PV. Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol. 1993:77:544-548.
8. Howes KA, Ransom N, Papermaster DS, Lasudry JGH, Albert DM, Windle JJ. Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev. 1994;8:1300-1310.
9. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972:26:239-257.
10. Portera-Cailliau C, Sung C-H, Nathans J, Adler R. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci USA. 1994:91:974-978.
11. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992; 119:493-501.
12. Nork TM, Millecchia LL, Poulsen G. Immunolocalization of the retinoblastoma protein in the human eye and in retinoblastoma. Invest Ophthalmol Vis Sci. 1994;35:2682-2692.
13. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature. 1991:352:345-347.
14. Bunt AH, Tso MO. Feulgen-positive deposits in retinoblastoma: incidence, composition, and ultrastructure. Arch Ophthalmol. 1981;99:144-150.
15. Dryja TP, Rapaport J, McGee TL, Nork TM, Schwartz TL. Molecular etiology of low-penetrance retinoblastoma in two pedigrees. Am J Hum Genet. 1993;52: 1122-1128.
16. Nork TM, Millecchia LL, Strickland BD, Linberg JV, Chao G-M. Selective loss of blue cones and rods in human retinal detachment. Arch Ophthalmol. 1995; 113:1066-1073.
17. Cook B, Lewis GP, Fisher SK, Adler R. Apoptotic photoreceptor degeneration in experimental retinal detachment. Invest Ophthalmol Vis Sci. 1995:36:990-996.
18. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol. 1995;146:1220-1234.
19. El-Deiry WS, Harper JW, O'Connor PM, et al. WAF1/CIP1 is induced in p53-mediated G, arrest and apoptosis. Cancer Res. 1994:54:1169-1174.
20. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993:75:817-825.
21. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991;51: 6304-6311.
22. Kastan MB, Zhan Q, El-Deiry WS, et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 1992;71:587-597.
23. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993;75:805-816.
24. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 1993:366:701-704.
25. Hamel PA, Gallie BL, Phillips RA. The retinoblastoma protein and cell cycle regulation. Trends Genet. 1992;8:180-185.
26. Nevins JR. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science. 1992:258:424-429.
27. Ryan JJ, Prochownik E, Gottlieb CA, et al. c-mycand bcl-2modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci U S A. 1994:91:5878-5882.
28. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human tax-gene. Cell. 1995:80:293-299.
29. Miyashita T, Harigai M, Hanada M, Reed JC. Identification of a p53-dependent negative response element in the bcl-2gene. Cancer Res. 1994;54:3131-3135.